Latest Breaking News On - Biological marker responses - Page 1 : comparemela.com

Data demonstrates halting of disease progression in patients with ALS at 24 weeks.

Stanley appelCoya therapeutics incAmyotrophic lateral sclerosisCoya therapeuticsLow doseConcept study evaluating safetyBiological marker responsesCombination therapyAmyotrophic lateral